GlobeNewswire 9/11/2025 Kyowa Kirin Announces Late-Breaking Abstract Presentation at the European Academy of Dermatology an...
GlobeNewswire 9/10/2025 CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class ...
GlobeNewswire 9/9/2025 HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Gener...
GlobeNewswire 9/9/2025 Numab Therapeutics Announces Leadership Transition and Appoints Angehrn Pavik as Chief Executive Off...
GlobeNewswire 9/9/2025 With Asthma-Related ER Visits Increasing, AAFA Names 2025 Asthma Capitals
GlobeNewswire 9/9/2025 Scenic Biotech Appoints Dr. Roland W. Bürli as CSO to Advance Pipeline of Modifier Therapies in Neur...
GlobeNewswire 9/9/2025 Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension...
GlobeNewswire 9/5/2025 Aisera Named a Visionary in 2025 Gartner® Magic Quadrant™ for AI Applications in IT Service Manageme...
GlobeNewswire 9/2/2025 Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer
GlobeNewswire 8/28/2025 CytomX Therapeutics to Present at Upcoming September Investor Conferences
GlobeNewswire 8/25/2025 I-Mab Announces the Appointment of Seasoned Biotech Executives to the Board of Directors and the Sci...
GlobeNewswire 8/25/2025 Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million
GlobeNewswire 8/20/2025 Cytokinetics Names Jim Daly to Board of Directors
GlobeNewswire 8/19/2025 Ligand to Participate in September Investor Conferences
GlobeNewswire 8/14/2025 Ligand Announces Closing of Convertible Senior Notes Offering
GlobeNewswire 8/14/2025 Apexon and Aisera Forge Strategic Partnership to Deliver Next-Generation Agentic AI Solutions for En...
GlobeNewswire 8/13/2025 Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
GlobeNewswire 8/13/2025 CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study
GlobeNewswire 8/12/2025 TScan Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire 8/12/2025 Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering
GlobeNewswire 8/11/2025 Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030
GlobeNewswire 8/7/2025 CytomX Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 8/7/2025 Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance
GlobeNewswire 8/6/2025 Aisera Launches Unify - The AI Industry’s First Open Architecture for Multi-Agent Orchestration
GlobeNewswire 8/6/2025 Royalty Pharma Reports Second Quarter 2025 Results